Viewing Study NCT01152502

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:47 AM

Ignite Modification Date: 2026-03-02 @ 6:23 AM

Study NCT ID: NCT01152502

Status: COMPLETED

Last Update Posted: 2010-06-29

First Post: 2010-06-28

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Paracetamol Metabolism in Post Operative Conditions

Sponsor: University Hospital, Clermont-Ferrand

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Overview

Official Title: Paracetamol Metabolism in Post Operative Conditions

Status: COMPLETED

Status Verified Date: 2010-06

Last Known Status: None

Delayed Posting: No

If Stopped, Why?: Not Stopped

Has Expanded Access: False

If Expanded Access, NCT#: N/A

Has Expanded Access, NCT# Status: N/A

Acronym: None

Brief Summary: Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)

Detailed Description: D-15 to D0: selection

* patient information and non-opposition obtained
* inclusion and non inclusion criteria check
* clinical exam

D-1 to D0 : 24 hours diuresis

D0 : operation day

Before anesthesia :

* urine collection (paracetamol metabolites dosage)
* blood sampling (glutathion and liver function test)

Surgery:

* 1st paracetamol intake before closing
* Then administration every 6 hours

D1 to D4 :

* 24 hours urine collection (metabolites dosage)
* blood sampling et D1 and D4(glutathion and liver function test)

D5 : final clinical exam

Study Oversight

Has Oversight DMC:

Is a FDA Regulated Drug?:

Is a FDA Regulated Device?:

Is an Unapproved Device?:

Is a PPSD?:

Is a US Export?:

Is an FDA AA801 Violation?: